Page last updated: 2024-08-25

n-methylscopolamine and Bladder Diseases

n-methylscopolamine has been researched along with Bladder Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Oki, T; Toma-Okura, A; Yamada, S	1

Other Studies

1 other study(ies) available for n-methylscopolamine and Bladder Diseases

Article	Year
Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Animals; Male; Mandelic Acids; N-Methylscopolamine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Saliva; Urinary Bladder Diseases	2006

Article

Year

Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion.

The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:3

Topics: Administration, Cutaneous; Administration, Oral; Animals; Male; Mandelic Acids; N-Methylscopolamine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Saliva; Urinary Bladder Diseases

2006